• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病与免疫营养:通过饮食和肠道微生物组调节的新型治疗方法。

Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

机构信息

Department of Paediatrics, BC Children's Hospital, University of British Columbia, Vancouver, BC, Canada.

出版信息

Immunology. 2018 Sep;155(1):36-52. doi: 10.1111/imm.12939. Epub 2018 May 16.

DOI:10.1111/imm.12939
PMID:29693729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6099178/
Abstract

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, thought to at least in part reflect an aberrant immune response to gut bacteria. IBD is increasing in incidence, particularly in populations that have recently immigrated to western countries. This suggests that environmental factors are involved in its pathogenesis. We hypothesize that the increase in IBD rates might reflect the consumption of an unhealthy Western diet, containing excess calories and lacking in key nutritional factors, such as fibre and vitamin D. Several recent studies have determined that dietary factors can dramatically influence the activation of immune cells and the mediators they release through a process called immunonutrition. Moreover, dietary changes can profoundly affect the balance of beneficial versus pathogenic bacteria in the gut. This microbial imbalance can alter levels of microbiota-derived metabolites that in turn can influence innate and adaptive intestinal immune responses. If the diet-gut microbiome disease axis does indeed underpin much of the 'western' influence on the onset and progression of IBD, then tremendous opportunity exists for therapeutic changes in lifestyle, to modulate the gut microbiome and to correct immune imbalances in individuals with IBD. This review highlights four such therapeutic strategies - probiotics, prebiotics, vitamin D and caloric restriction - that have the potential to improve and add to current IBD treatment regimens.

摘要

炎症性肠病(IBD)是一种胃肠道的慢性炎症性疾病,至少部分反映了对肠道细菌的异常免疫反应。IBD 的发病率正在上升,特别是在最近移民到西方国家的人群中。这表明环境因素参与了其发病机制。我们假设 IBD 发病率的增加可能反映了不健康的西方饮食的摄入,这种饮食含有过多的卡路里,缺乏关键的营养因素,如纤维和维生素 D。最近的几项研究已经确定,饮食因素可以通过一种称为免疫营养的过程,显著影响免疫细胞的激活及其释放的介质。此外,饮食的改变可以深刻地影响肠道中有益菌和致病菌的平衡。这种微生物失衡可以改变微生物衍生代谢物的水平,进而影响肠道先天和适应性免疫反应。如果饮食-肠道微生物组-疾病轴确实是“西方”对 IBD 的发病和进展产生影响的基础,那么在生活方式、调节肠道微生物组和纠正 IBD 患者免疫失衡方面,就有巨大的治疗机会。这篇综述强调了四种有潜力改善和补充当前 IBD 治疗方案的治疗策略,即益生菌、益生元、维生素 D 和热量限制。

相似文献

1
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.炎症性肠病与免疫营养:通过饮食和肠道微生物组调节的新型治疗方法。
Immunology. 2018 Sep;155(1):36-52. doi: 10.1111/imm.12939. Epub 2018 May 16.
2
Vitamin D signaling in intestinal innate immunity and homeostasis.维生素D在肠道固有免疫及内环境稳定中的信号传导
Mol Cell Endocrinol. 2017 Sep 15;453:68-78. doi: 10.1016/j.mce.2017.04.010. Epub 2017 Apr 12.
3
Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention.饮食、肠道微生物组和表观遗传学:与炎症性肠病的新兴联系及管理和预防的前景。
Nutrients. 2017 Aug 30;9(9):962. doi: 10.3390/nu9090962.
4
Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.炎症性肠病中肠道微生物群的治疗性调节:更多问题有待解答。
J Dig Dis. 2016 Dec;17(12):800-810. doi: 10.1111/1751-2980.12422.
5
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.目前对微生物群和饮食疗法治疗炎症性肠病的理解。
J Microbiol. 2018 Mar;56(3):189-198. doi: 10.1007/s12275-018-8049-8. Epub 2018 Feb 28.
6
The microbiome and inflammatory bowel disease.肠道微生物群与炎症性肠病。
J Allergy Clin Immunol. 2020 Jan;145(1):16-27. doi: 10.1016/j.jaci.2019.11.003.
7
The role of diet in the prevention and treatment of Inflammatory Bowel Diseases.饮食在炎症性肠病预防和治疗中的作用。
Acta Biomed. 2018 Dec 17;89(9-S):60-75. doi: 10.23750/abm.v89i9-S.7952.
8
Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?微生物群在炎症性肠病发病机制和治疗中的作用:一切都与饮食有关吗?
Nutr Clin Pract. 2015 Dec;30(6):760-79. doi: 10.1177/0884533615606898. Epub 2015 Oct 9.
9
Gut microbiota and inflammatory bowel disease: so far so gut!肠道微生物群与炎症性肠病:迄今为止,肠道的情况就是这样!
Minerva Gastroenterol Dietol. 2017 Dec;63(4):373-384. doi: 10.23736/S1121-421X.17.02386-8. Epub 2017 Mar 14.
10
Fiber and Prebiotic Interventions in Pediatric Inflammatory Bowel Disease: What Role Does the Gut Microbiome Play?膳食纤维和益生元干预小儿炎症性肠病:肠道微生物组扮演什么角色?
Nutrients. 2020 Oct 20;12(10):3204. doi: 10.3390/nu12103204.

引用本文的文献

1
Fasting elicits gut microbiome signature changes that extend to type 1 diabetes patients.禁食会引发肠道微生物群特征变化,这种变化在1型糖尿病患者中也存在。
Front Endocrinol (Lausanne). 2025 Aug 13;16:1623800. doi: 10.3389/fendo.2025.1623800. eCollection 2025.
2
Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer.MS4A12表达升高表明直肠癌患者对同步放化疗耐药且生存期较差。
Radiat Oncol. 2025 Aug 9;20(1):126. doi: 10.1186/s13014-025-02709-5.
3
Millet Quinic Acid Relieves Colitis by Regulating Gut Microbiota and Inhibiting MyD88/NF-κB Signaling Pathway.小米奎尼酸通过调节肠道微生物群和抑制MyD88/NF-κB信号通路缓解结肠炎。
Foods. 2025 Jun 26;14(13):2267. doi: 10.3390/foods14132267.
4
Comparison of age-related inflammation and oxidative stress in two lemur species.两种狐猴物种中与年龄相关的炎症和氧化应激的比较。
J Comp Physiol B. 2025 Jul 2. doi: 10.1007/s00360-025-01619-y.
5
Probiotic-induced enrichment of increases gut microbiome wellness index and maps to lower host blood glucose levels.益生菌诱导的[具体物质]富集可提高肠道微生物群健康指数,并与宿主较低的血糖水平相关。 (注:原文中“increases gut microbiome wellness index and maps to lower host blood glucose levels”部分缺少关键信息,推测是“Probiotic-induced enrichment of [具体物质]”,这里按推测完整意思翻译,具体需根据完整准确原文调整)
Gut Microbes. 2025 Dec;17(1):2520407. doi: 10.1080/19490976.2025.2520407. Epub 2025 Jun 14.
6
Exogenous TSG-6 treatment alleviates DSS-induced colitis in mice by modulating Pou2f3 and promoting tuft cells differentiation.外源性TSG-6治疗通过调节Pou2f3和促进簇状细胞分化减轻DSS诱导的小鼠结肠炎。
Mol Med. 2025 Apr 29;31(1):157. doi: 10.1186/s10020-025-01230-5.
7
Enigmatic link between familial mediterranean fever and dietary components: a novel approach to personalized nutrition.家族性地中海热与饮食成分之间的神秘联系:个性化营养的新方法。
BMC Nutr. 2025 Apr 25;11(1):85. doi: 10.1186/s40795-025-01071-9.
8
Exploring the Connections: Autophagy, Gut Microbiota, and Inflammatory Bowel Disease Pathogenesis.探索关联:自噬、肠道微生物群与炎症性肠病发病机制
J Inflamm Res. 2024 Dec 5;17:10453-10470. doi: 10.2147/JIR.S483958. eCollection 2024.
9
Use of Treatment and Self-Management Methods: Perspectives and Decisions of Patients With Ulcerative Colitis.治疗与自我管理方法的使用:溃疡性结肠炎患者的观点与决策
Am J Lifestyle Med. 2024 Apr 2:15598276241243300. doi: 10.1177/15598276241243300.
10
Didymin Ameliorates Dextran Sulfate Sodium (DSS)-Induced Ulcerative Colitis by Regulating Gut Microbiota and Amino Acid Metabolism in Mice.地锦草素通过调节小鼠肠道微生物群和氨基酸代谢改善葡聚糖硫酸钠(DSS)诱导的溃疡性结肠炎。
Metabolites. 2024 Oct 14;14(10):547. doi: 10.3390/metabo14100547.

本文引用的文献

1
Associations between inflammatory bowel diseases and vitamin D.炎症性肠病与维生素 D 之间的关联。
Crit Rev Food Sci Nutr. 2019;59(8):1347-1356. doi: 10.1080/10408398.2017.1406333. Epub 2017 Dec 13.
2
Pharmacokinetic and Pharmacodynamic Modeling of Serum Etrolizumab and Circulating β7 Receptor Occupancy in Patients With Ulcerative Colitis.溃疡性结肠炎患者血清依特立珠单抗的药代动力学和药效学建模及循环β7 受体占有率。
J Clin Pharmacol. 2018 Mar;58(3):386-398. doi: 10.1002/jcph.1031. Epub 2017 Nov 26.
3
Metabolic pressure and the breach of immunological self-tolerance.代谢压力与免疫自身耐受的破坏。
Nat Immunol. 2017 Oct 18;18(11):1190-1196. doi: 10.1038/ni.3851.
4
The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.西方饮食和营养对黏膜界面微生物群和免疫反应的影响。
Front Immunol. 2017 Jul 28;8:838. doi: 10.3389/fimmu.2017.00838. eCollection 2017.
5
Adapting to obesity with adipose tissue inflammation.适应脂肪组织炎症导致的肥胖。
Nat Rev Endocrinol. 2017 Nov;13(11):633-643. doi: 10.1038/nrendo.2017.90. Epub 2017 Aug 11.
6
Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion.微生物群激活的PPAR-γ信号传导抑制生态失调的肠杆菌科细菌扩张。
Science. 2017 Aug 11;357(6351):570-575. doi: 10.1126/science.aam9949.
7
Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.失调的变形菌扩张:上皮功能障碍的微生物特征。
Curr Opin Microbiol. 2017 Oct;39:1-6. doi: 10.1016/j.mib.2017.07.003. Epub 2017 Aug 4.
8
Current and Future Targets for Mucosal Healing in Inflammatory Bowel Disease.炎症性肠病黏膜愈合的当前及未来目标
Visc Med. 2017 Mar;33(1):82-88. doi: 10.1159/000458006. Epub 2017 Feb 16.
9
Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics.专家共识文件:国际益生菌和益生元科学协会(ISAPP)关于益生元定义和范围的共识声明。
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491-502. doi: 10.1038/nrgastro.2017.75. Epub 2017 Jun 14.
10
Prolonged fasting suppresses mitochondrial NLRP3 inflammasome assembly and activation via SIRT3-mediated activation of superoxide dismutase 2.长期禁食通过SIRT3介导的超氧化物歧化酶2激活来抑制线粒体NLRP3炎性小体的组装和激活。
J Biol Chem. 2017 Jul 21;292(29):12153-12164. doi: 10.1074/jbc.M117.791715. Epub 2017 Jun 5.